paper-with-me

홈 › Papers

Population Pharmacokinetic Study of Tacrolimus in Pediatric Patients with Primary Nephrotic Syndrome: A Comparison of Linear and Nonlinear Michaelis Menten Pharmacokinetic Model

2020-02-26

Background Little is known about the population pharmacokinetics (PPK) of tacrolimus (TAC) in pediatric primary nephrotic syndrome (PNS). This study aimed to compare the predictive performance between nonlinear and linear PK models and investigate the significant factors of TAC PK characteristics in pediatric PNS. Methods Data were obtained from 71 pediatric patients with PNS, along with 525 TAC trough concentrations at steady state. The demographic, medical, and treatment details were collected. Genetic polymorphisms were analyzed. The PPK models were developed using nonlinear mixed effects model software. Two modeling strategies, linear compartmental and nonlinear Michaelis Menten (MM) models, were evaluated and compared. Results Body weight, age, daily dose of TAC, co-therapy drugs (including azole antifungal agents and diltiazem), and CYP3A5*3 genotype were important factors in the final linear model (onecompartment model), whereas only body weight, codrugs, and CYP3A5*3 genotype were the important factors in the nonlinear MM model. Apparent clearance and volume of distribution in the final linear model were 7.13 L/h and 142 L, respectively. The maximal dose rate (Vmax) of the nonlinear MM model was 1.92 mg/day and the average concentration at steady state at half-Vmax (Km) was 1.98 ng/mL. The nonlinear model described the data better than the linear model. Dosing regimens were proposed based on the nonlinear PK model.Conclusion Our findings demonstrate that the nonlinear MM model showed better predictive performance than the linear compartmental model, providing reliable support for optimizing TAC dosing and adjustment in children with PNS.

📄 PDF Abstract BibTeX arXiv:1912.01769

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients

2020-02-01 · Xiaojun Cai, Huizhu Song, Zheng Jiao, Hang Yang 외

We aimed to develop a population pharmacokinetic model of tacrolimus in Chinese lung transplant recipients, and propose model based dosing regimens for individualized treatment. We obtained 807 tacrolimus whole blood con…

Predicting tacrolimus exposure in kidney transplanted patients using machine learning

2022-05-09 · Andrea M. Storås, Anders Åsberg, Pål Halvorsen, Michael A. Riegler 외

Tacrolimus is one of the cornerstone immunosuppressive drugs in most transplantation centers worldwide following solid organ transplantation. Therapeutic drug monitoring of tacrolimus is necessary in order to avoid rejec…

BIG-bench Machine Learning

Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients

2019-11-29

Background:Diverse tacrolimus population pharmacokinetic models in adult liver transplant recipients have been established to describe the PK characteristics of tacrolimus in the last two decades. However, their extrapol…

Prediction

Uncovering Population PK Covariates from VAE-Generated Latent Spaces

2025-05-05 · Diego Perazzolo, Chiara Castellani, Enrico Grisan

Population pharmacokinetic (PopPK) modelling is a fundamental tool for understanding drug behaviour across diverse patient populations and enabling personalized dosing strategies to improve therapeutic outcomes. A key ch…

feature selectionregression

Latent Neural-ODE for Model-Informed Precision Dosing: Overcoming Structural Assumptions in Pharmacokinetics

2026-02-03 · Benjamin Maurel, Agathe Guilloux, Sarah Zohar, Moreno Ursino 외 arxiv

Accurate estimation of tacrolimus exposure, quantified by the area under the concentration-time curve (AUC), is essential for precision dosing after renal transplantation. Current practice relies on population pharmacoki…